|
Market Closed -
Nasdaq
06:00:00 20/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 18.39 USD | +6.98% |
|
+34.14% | +7.07% |
| 14/08 | Omeros Corporation Announces Appointment of Joseph Schocken as Director and Audit Committee Member, Effective August 12, 2026 | CI |
| 13/08 | Omeros Swings to Q2 Adjusted Earnings; Shares up | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OMEROS CORPORATION | Bio Therapeutic Drugs | +6.98% | +34.14% | +7.07% | +321.79% | +33.55% | 1.33B |  | | |
- Stock Market
- Stocks
- OMER Stock
- Charts Omeros Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
